Totiger, T. M., Chiraphapphaiboon, W., Baca, Y., Chaudhry, S., Notti, R. Q., Montoya, S., Chojnacka, M., Gaidosh, G., Afaghani, J., Affer, M., Armstrong, C., Kavanaugh, P. M., Karaca, E., Zabroski, J., Lewis, M., Maye, A., Jahn, J., Soni, R. K., Bilbao, D., … Taylor, J. (2025). XPO1R749Q Mutations Co-occur with POLE Mutations in Cancer and can be Targeted to Overcome Chemoresistance. Cancer Research. https://doi.org/10.1158/0008-5472.can-24-3112

Alvarez-Torres, M. del M., Fu, X., & Rabadan, R. (2025). Illuminating the Noncoding Genome in Cancer using Artificial Intelligence. Cancer Research. https://doi.org/10.1158/0008-5472.can-25-0482

Izar, B., & Kim, M. (2024). Peritumoral Venous Vessels: Autobahn and Portal for T cells to Melanoma Brain Metastasis. Cancer Research. https://doi.org/10.1158/0008-5472.can-24-4054

Carpenter, E. S., Vendramini-Costa, D. B., Hasselluhn, M. C., Maitra, A., Olive, K. P., Cukierman, E., Pasca di Magliano, M., & Sherman, M. H. (2024). Pancreatic Cancer–Associated Fibroblasts: Where Do We Go from Here? Cancer Research, 84(21), 3505–3508. https://doi.org/10.1158/0008-5472.can-24-2860

Pareja, F., Dopeso, H., Wang, Y. K., Gazzo, A. M., Brown, D. N., Banerjee, M., Selenica, P., Bernhard, J. H., Derakhshan, F., da Silva, E. M., Colon-Cartagena, L., Basili, T., Marra, A., Sue, J., Ye, Q., Da Cruz Paula, A., Yeni Yildirim, S., Pei, X., Safonov, A., … Reis-Filho, J. S. (2024). A Genomics-Driven Artificial Intelligence-Based Model Classifies Breast Invasive Lobular Carcinoma and Discovers CDH1 Inactivating Mechanisms. Cancer Research. https://doi.org/10.1158/0008-5472.can-24-1322

Torres-Diz, M., Reglero, C., Falkenstein, C. D., Castro, A., Hayer, K. E., Radens, C. M., Quesnel-Vallières, M., Ang, Z., Sehgal, P., Li, M. M., Barash, Y., Tasian, S. K., Ferrando, A., & Thomas-Tikhonenko, A. (2024). An Alternatively Spliced Gain-of-Function NT5C2 Isoform Contributes to Chemoresistance in Acute Lymphoblastic Leukemia. Cancer Research. https://doi.org/10.1158/0008-5472.can-23-3804

Zhakula-Kostadinova, N., & Taylor, A. M. (2024). Patterns of Aneuploidy and Signaling Consequences in Cancer. Cancer Research. https://doi.org/10.1158/0008-5472.can-24-0169

Ding, Y. C., Song, H., Adamson, A. W., Schmolze, D., Hu, D., Huntsman, S., Steele, L., Patrick, C. S., Tao, S., Hernandez, N., Adams, C. D., Fejerman, L., Gardner, K., Nápoles, A. M., Pérez-Stable, E. J., Weitzel, J. N., Bengtsson, H., Huang, F. W., Neuhausen, S. L., & Ziv, E. (2023). Profiling the Somatic Mutational Landscape of Breast Tumors from Hispanic/Latina Women Reveals Conserved and Unique Characteristics. Cancer Research, 83(15), 2600–2613. https://doi.org/10.1158/0008-5472.can-22-2510

Park, H.-R., Shiva, A., Cummings, P., Kim, S., Kim, S., Lee, E., Leong, A., Chowdhury, S., Shawber, C., Carvajal, R., Thurston, G., An, J.-Y., Lund, A. W., Yang, H. W., & Kim, M. (2023). Angiopoietin-2–Dependent Spatial Vascular Destabilization Promotes T-cell Exclusion and Limits Immunotherapy in Melanoma. Cancer Research, 83(12), 1968–1983. https://doi.org/10.1158/0008-5472.can-22-2838

DeBlasi, J. M., Falzone, A., Caldwell, S., Prieto-Farigua, N., Prigge, J. R., Schmidt, E. E., Chio, I. I. C., Karreth, F. A., & DeNicola, G. M. (2023). Distinct Nrf2 Signaling Thresholds Mediate Lung Tumor Initiation and Progression. Cancer Research, 83(12), 1953–1967. https://doi.org/10.1158/0008-5472.can-22-3848

Lo, E. K. W., Mears, B. M., Maurer, H. C., Idrizi, A., Hansen, K. D., Thompson, E. D., Hruban, R. H., Olive, K. P., & Feinberg, A. P. (2023). Comprehensive DNA Methylation Analysis Indicates That Pancreatic Intraepithelial Neoplasia Lesions Are Acinar-Derived and Epigenetically Primed for Carcinogenesis. Cancer Research, 83(11), 1905–1916. https://doi.org/10.1158/0008-5472.can-22-4052

Guan, L., Nambiar, D. K., Cao, H., Viswanathan, V., Kwok, S., Hui, A. B., Hou, Y., Hildebrand, R., von Eyben, R., Holmes, B. J., Zhao, J., Kong, C. S., Wamsley, N., Zhang, W., Major, M. B., Seol, S. W., Sunwoo, J. B., Hayes, D. N., Diehn, M., & Le, Q.-T. (2023). NFE2L2Mutations Enhance Radioresistance in Head and Neck Cancer by Modulating Intratumoral Myeloid Cells. Cancer Research, 83(6), 861–874. https://doi.org/10.1158/0008-5472.can-22-1903

Kuzuoglu-Ozturk, D., Aksoy, O., Schmidt, C., Lea, R., Larson, J. D., Phelps, R. R. L., Nasholm, N., Holt, M., Contreras, A., Huang, M., Wong-Michalak, S., Shao, H., Wechsler-Reya, R., Phillips, J. J., Gestwicki, J. E., Ruggero, D., & Weiss, W. A. (2022). N-myc–Mediated Translation Control Is a Therapeutic Vulnerability in Medulloblastoma. Cancer Research, 83(1), 130–140. https://doi.org/10.1158/0008-5472.can-22-0945

Abate-Shen, C., & Nunes de Almeida, F. (2022). Establishment of the LNCaP Cell Line – The Dawn of an Era for Prostate Cancer Research. Cancer Research, 82(9), 1689–1691. https://doi.org/10.1158/0008-5472.can-22-1065

Wang, F., Liu, Y., Qiu, W., Shum, E., Feng, M., Zhao, D., Zheng, D., Borczuk, A., Cheng, H., & Halmos, B. (2022). Functional Analysis of MET Exon 14 Skipping Alteration in Cancer Invasion and Metastatic Dissemination. Cancer Research, 82(7), 1365–1379. https://doi.org/10.1158/0008-5472.can-21-1327

Sen, A., Prager, B. C., Zhong, C., Park, D., Zhu, Z., Gimple, R. C., Wu, Q., Bernatchez, J. A., Beck, S., Clark, A. E., Siqueira-Neto, J. L., Rich, J. N., & McVicker, G. (2021). Leveraging Allele-Specific Expression for Therapeutic Response Gene Discovery in Glioblastoma. Cancer Research, 82(3), 377–390. https://doi.org/10.1158/0008-5472.can-21-0810

Gil, V., Miranda, S., Riisnaes, R., Gurel, B., D’Ambrosio, M., Vasciaveo, A., Crespo, M., Ferreira, A., Brina, D., Troiani, M., Sharp, A., Sheehan, B., Christova, R., Seed, G., Figueiredo, I., Lambros, M., Dolling, D., Rekowski, J., Alajati, A., … de Bono, J. (2021). HER3 Is an Actionable Target in Advanced Prostate Cancer. Cancer Research, 81(24), 6207–6218. https://doi.org/10.1158/0008-5472.can-21-3360

Decker, A. R., Harimoto, T., Sastra, S. A., Danino, T., & Olive, K. P. (2021). Abstract PO-033: Bacterial cytotoxin therapy limits tumor growth for pancreatic ductal adenocarcinoma. Cancer Research, 81(22_Supplement), PO-033-PO-033. https://doi.org/10.1158/1538-7445.panca21-po-033

Park, S., Rong, L., Owczarek, T. B., Bernardo, M. D., Shoulson, R. L., Chua, C.-W., Kim, J. Y., Lankarani, A., Chakrapani, P., Syed, T., McKiernan, J. M., Solit, D. B., Shen, M. M., Al-Ahmadie, H. A., & Abate-Shen, C. (2021). Novel Mouse Models of Bladder Cancer Identify a Prognostic Signature Associated with Risk of Disease Progression. Cancer Research, 81(20), 5161–5175. https://doi.org/10.1158/0008-5472.can-21-1254

Geethadevi, A., Nair, A., Parashar, D., Ku, Z., Xiong, W., Deng, H., Li, Y., George, J., McAllister, D. M., Sun, Y., Kadamberi, I. P., Gupta, P., Dwinell, M. B., Bradley, W. H., Rader, J. S., Rui, H., Schwabe, R. F., Zhang, N., Pradeep, S., … Chaluvally-Raghavan, P. (2021). Oncostatin M Receptor–Targeted Antibodies Suppress STAT3 Signaling and Inhibit Ovarian Cancer Growth. Cancer Research, 81(20), 5336–5352. https://doi.org/10.1158/0008-5472.can-21-0483

Khan, I. Z., Del Guzzo, C. A., Shao, A., Cho, J., Du, R., Cohen, A. O., & Owens, D. M. (2021). The CD200–CD200R Axis Promotes Squamous Cell Carcinoma Metastasis via Regulation of Cathepsin K. Cancer Research, 81(19), 5021–5032. https://doi.org/10.1158/0008-5472.can-20-3251